The role of IKKβ in venezuelan equine encephalitis virus infection

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Amaya, Moushimi ^a   Voss, Kelsey ^a   Sampey, Gavin ^a   Senina, Svetlana ^a   De La Fuente, Cynthia ^a   Mueller, Claudius ^a   Calvert, Valerie ^a   Kehn Hall, Kylene ^a   Carpenter, Calvin ^a   Kashanchi, Fatah ^a   Bailey, Charles ^a   Mogelsvang, Soren ^b   Petricoin, Emanuel ^a   Narayanan, Aarthi ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b Serpin Pharma LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; I KAPPA B KINASE BETA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTRUCTURAL PROTEIN 3; VIRUS RNA; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; I KAPPA B KINASE; NITRILE; SULFONE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SURVIVAL TIME; VENEZUELAN EQUINE ENCEPHALITIS; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; CELL LINE; DRUG EFFECTS; GUINEA PIG; HOST PATHOGEN INTERACTION; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALS; CELL LINE; DOWN-REGULATION; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; GUINEA PIGS; HOST-PATHOGEN INTERACTIONS; HUMANS; I-KAPPA B KINASE; MICE; NEURONS; NF-KAPPA B; NITRILES; SIGNAL TRANSDUCTION; SULFONES; VIRAL LOAD; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84897806246     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086745     Document Type: Article

References (34)

1. Kim DY, Atasheva S, Frolova EI, Frolov I (2013) Venezuelan equine encephalitis virus nsP2 protein regulates packaging of viral genome into infectious virions. J Virol.
2. Foy NJ, Akhrymuk M, Akhrymuk I, Atasheva S, Bopda-Waffo A, et al. (2013) Hypervariable Domains of nsP3 Proteins of New World and Old World Alphaviruses Mediate Formation of Distinct, Virus-Specific Protein Complexes. J Virol 87: 1997-2010.
3. Lamb K, Lokesh GL, Sherman M, Watowich S (2010) Structure of a Venezuelan equine encephalitis virus assembly intermediate isolated from infected cells. Virology 406: 261-269.
4. Aguilar PV, Greene IP, Coffey LL, Medina G, Moncayo AC, et al. (2004) Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis 10: 880-888. (Pubitemid 38552757)
5. Steele KE, Twenhafel NA (2010) REVIEW PAPER: pathology of animal models of alphavirus encephalitis. Vet Pathol 47: 790-805.
6. Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, et al. (1996) Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet 348: 436-440. (Pubitemid 26267875)
7. Zacks MA, Paessler S (2010) Encephalitic alphaviruses. Vet Microbiol 140: 281-286.
8. Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC (2004) Venezuelan equine encephalitis. Annu Rev Entomol 49: 141-174. (Pubitemid 38192420)
9. Garmashova N, Gorchakov R, Volkova E, Paessler S, Frolova E, et al. (2007) The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol 81: 2472-2484.
10. Jose J, Snyder JE, Kuhn RJ (2009) A structural and functional perspective of alphavirus replication and assembly. Future Microbiol 4: 837-856.
11. Weaver SC, Barrett AD (2004) Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol 2: 789-801. (Pubitemid 39317460)
12. Hai T, Yeung ML, Wood TG, Wei Y, Yamaoka S, et al. (2006) An alternative splice product of IkappaB kinase (IKKgamma), IKKgamma-delta, differentially mediates cytokine and human T-cell leukemia virus type 1 tax-induced NF-kappaB activation. J Virol 80: 4227-4241.
13. Le Negrate G (2012) Viral interference with innate immunity by preventing NF-kappaB activity. Cell Microbiol 14: 168-181.
14. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
15. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62.
16. Solt LA, May MJ (2008) The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol Res 42: 3-18.
17. Gamble C, McIntosh K, Scott R, Ho KH, Plevin R, et al. (2012) Inhibitory kappa B Kinases as targets for pharmacological regulation. Br J Pharmacol 165: 802-819.
18. Israel A (2010) The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2: a000158.
19. Karin M (1999) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 274: 27339-27342.
20. Liu F, Xia Y, Parker AS, Verma IM (2012) IKK biology. Immunol Rev 246: 239-253.
21. Shifera AS (2010) Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB. Biochem Biophys Res Commun 396: 585-589.
22. Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S (2006) Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 25: 6844-6867. (Pubitemid 44657856)
23. Narayanan A, Kehn-Hall K, Senina S, Lundberg L, Van Duyne R, et al. (2012) Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem 287: 33198-33214.
24. Kehn-Hall K, Narayanan A, Lundberg L, Sampey G, Pinkham C, et al. (2012) Modulation of GSK-3beta activity in Venezuelan equine encephalitis virus infection. PLoS One 7: e34761.
25. Tergaonkar V, Bottero V, Ikawa M, Li Q, Verma IM (2003) IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy. Mol Cell Biol 23: 8070-8083. (Pubitemid 37377499)
26. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005) A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J Biol Chem 280: 10326-10332. (Pubitemid 40395889)
27. Narayanan A, Sampey G, Van Duyne R, Guendel I, Kehn-Hall K, et al. (2012) Use of ATP analogs to inhibit HIV-1 transcription. Virology 432: 219-231.
28. Sharma A, Maheshwari RK (2009) Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain. J Gen Virol 90: 1836-1847.
29. Sharma A, Bhattacharya B, Puri RK, Maheshwari RK (2008) Venezuelan equine encephalitis virus infection causes modulation of inflammatory and immune response genes in mouse brain. BMC Genomics 9: 289.
30. Lee J, Rhee MH, Kim E, Cho JY (2012) BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets. Mediators Inflamm 2012: 416036.
31. Garcia MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, et al. (2005) Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines. Leuk Res 29: 1425-1434. (Pubitemid 41562245)
32. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, et al. (1997) Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096-21103. (Pubitemid 27373968)
33. Keller SA, Schattner EJ, Cesarman E (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96: 2537-2542.
34. Charles PC, Trgovcich J, Davis NL, Johnston RE (2001) Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Virology 284: 190-202. (Pubitemid 32523221)